Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Company Description (as filed with the SEC)
The following discussion should be read in conjunction with our consolidated financial statements and the related notes and other financial information appearing elsewhere in this Annual Report on Form 10-K. Overview We are a hybrid device and gene therapy biotechnology company focused on designing, developing and commercializing innovative and proprietary medical approaches for the treatment of cancer where currently approved therapies are inadequate based on their efficacy or side effects. Our Company was incorporated under the laws of Nevada on February 8, 2008 under the name "Netventory Solutions Inc." Initially, we provided online inventory services to small and medium sized companies. On March 1, 2011, we changed our name to "OncoSec Medical Incorporated." In March 2011, we acquired certain assets related to the use of drug-medical device combination products for the treatment of various cancers from Inovio Pharmaceuticals, Inc. ("Inovio"). ... More ...
Where does ONCS fit in the risk graph?
|Annual EPS Est:||$-1.2|
|Quarterly EPS Est:||-0.44|